Equity
Total Equity
Thermo Fisher Scientific Total Equity decreased by 2.8% to $51.93B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $49.39B to $51.93B. Over 5 years (FY 2020 to FY 2025), Total Equity shows an upward trend with a 9.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ4 2012
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase indicates growth in net assets through earnings or capital contributions, while a decrease signals losses or capital distributions.
Detailed definition
This represents the total net assets of the company attributable to the parent company's shareholders, calculated as tot...
Peer comparison
Standard metric for all public companies; used to calculate Return on Equity (ROE) across the industry.
Metric ID:
total_stockholders_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.85B | $38.71B | $40.79B | $40.96B | $42.29B | $43.55B | $43.98B | $42.26B | $43.75B | $45.33B | $46.74B | $45.52B | $47.43B | $48.99B | $49.58B | $49.39B | $50.51B | $51.02B | $53.41B | $51.93B |
| QoQ Change | — | +5.0% | +5.4% | +0.4% | +3.3% | +3.0% | +1.0% | -3.9% | +3.5% | +3.6% | +3.1% | -2.6% | +4.2% | +3.3% | +1.2% | -0.4% | +2.3% | +1.0% | +4.7% | -2.8% |
| YoY Change | — | — | — | — | +14.8% | +12.5% | +7.8% | +3.2% | +3.4% | +4.1% | +6.3% | +7.7% | +8.4% | +8.1% | +6.1% | +8.5% | +6.5% | +4.1% | +7.7% | +5.2% |
Range$36.85B – $53.41B
CAGR+7.5%
Avg YoY Growth+7.1%
Median YoY Growth+7.1%
Total Equity at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's total equity?
- Thermo Fisher Scientific (TMO) reported total equity of $51.93B in Q1 2026.
- How has Thermo Fisher Scientific's total equity changed year-over-year?
- Thermo Fisher Scientific's total equity increased by 5.2% year-over-year, from $49.39B to $51.93B.
- What is the long-term trend for Thermo Fisher Scientific's total equity?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's total equity has grown at a 9.1% compound annual growth rate (CAGR), from $34.51B to $53.41B.
- What does total equity mean?
- The net value of the company belonging to shareholders, calculated as assets minus liabilities.